Prof. Il-Kang Na became the new director of the BIH Charité Clinician Scientist Program (CSP) on January 1, 2023. The BIH Johanna Quandt Professor succeeds Prof. Duška Dragun, who headed the CSP until her untimely death in late 2020. In 2021 and…
When cells exchange metabolic products with other cells, they live longer. This new finding comes from a research team at Charité – Universitätsmedizin Berlin, which made the discovery in a study using yeast cells. The fact that these exchanges…
The EU project TEF-Health aims to test and validate innovative artificial intelligence (AI) and robotics solutions for the healthcare sector and accelerate their path to market. It is led by Prof. Petra Ritter, who heads the Brain Simulation Section…
An event held in cooperation with the Biotechnologieverbund Berlin-Brandenburg e.V., BBB; the Paul-Ehrlich-Institut; the Central Authority of the Länder for Health Protection with regard to Medicinal Products and Medical Devices, ZLG; the German Stem…
Deep brain stimulation (DBS) is an established treatment option for patients suffering from Parkinson's disease. In a neurosurgical procedure two electrodes are implanted in the brain to permanently stimulate specific brain regions. Setting the…
Body cells burn off fat reserves when nutrient supply from food ceases. A team led by Professor Volker Haucke and Dr. Wonyul Jang from the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) has now discovered a previously unknown mechanism…
New appointment
Prof Silvia Vignolini, Ph.D. is founding the new Department "Sustainable and Bio-inspired Materials" at the Max Planck Institute of Colloids and Interfaces (MPICI). On January 1st, the top physicist will move to Potsdam from the…
DSM rolls out Labtwin's AI and voice powered digital lab assistant
Today, Royal DSM N.V., a global company specializing in health, nutrition, and sustainable living, and LabTwin GmbH, the leading voice and AI-powered digital lab assistant, announce…
Alzheimer’s disease is the most common cause of dementia, but it is not easily treatable. One potential therapy is deep brain stimulation delivered by a kind of pacemaker. A team of researchers at Charité – Universitätsmedizin Berlin has found that…
Therabest and Glycotope to assess Therabest’s iPSC-derived NK cell product TB-100 in combination with Glycotope’s GT-00AxIL15 immuno-cytokine for development in triple negative breast cancer
